FDA Announces New Nationwide Blood Pressure Medication Recall
📍 How it ended
The FDA announced a nationwide recall of the blood‑pressure medication chlorthalidone, classifying the recall as a Class II risk and citing a quality issue that caused the drug to fail dissolution specifications. More than 13,000 bottles were pulled from the market, prompting coverage across multiple outlets.
Epilogue added 42d ago, after coverage quieted.
The coverage curve
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
- Velocity & Diffusion: Coverage escalated across 9 distinct news outlets with 9 published articles, achieving a live velocity of 10.
- Predictive Outlook: Newsylist algorithmic models forecast this story will remain a dominant headline through tomorrow.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"FDA Announces New Nationwide Blood Pressure Medication Recall" developed substantial multi-source reporting across the Business sector, tracked across 8 distinct newsrooms by Newsylist.
Key reporting was led by Dallas News, Newsday, newsnationnow.com and USA Today. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 45d ago.
Coverage (9)
-
-
-
-
-
-
-
-
-
FDA Announces New Nationwide Blood Pressure Medication Recall aol.com · 47d ago broke it first
Quick answers
What drove coverage for FDA Announces New Nationwide Blood Pressure Medication Recall?
Coverage spiked when 8 independent newsrooms published 8 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.